Results 91 to 100 of about 828,653 (197)

Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview

open access: yesFrontiers in Immunology, 2017
Single domain antibodies (sdAbs) are gaining a reputation as superior recognition elements as they combine the advantages of the specificity and affinity found in conventional antibodies with high stability and solubility.
Ellen R. Goldman   +3 more
doaj   +1 more source

The Chlamydia trachomatis Type III Secretion Chaperone Slc1 Engages Multiple Early Effectors, Including TepP, a Tyrosine-phosphorylated Protein Required for the Recruitment of CrkI-II to Nascent Inclusions and Innate Immune Signaling [PDF]

open access: yes, 2014
Chlamydia trachomatis, the causative agent of trachoma and sexually transmitted infections, employs a type III secretion (T3S) system to deliver effector proteins into host epithelial cells to establish a replicative vacuole.
Bastidas, Robert J.   +6 more
core   +3 more sources

Single-Domain Antibody-Based Protein Degrader for Synucleinopathies

open access: yesMolecular Neurodegeneration
AbstractSynucleinopathies are a group of neurodegenerative diseases characterized by the accumulation of α-synuclein (α-syn) in the brain, leading to motor and neuropsychiatric symptoms. Currently, there are no known cures for synucleinopathies, and treatments mainly focus on symptom management.
Yixiang Jiang   +7 more
openaire   +4 more sources

Biotechnological applications of recombinant single-domain antibody fragments [PDF]

open access: yesMicrobial Cell Factories, 2011
Single-domain antibody fragments possess structural features, such as a small dimension, an elevated stability, and the singularity of recognizing epitopes non-accessible for conventional antibodies that make them interesting for several research and biotechnological applications.The discovery of the single-domain antibody's potentials has stimulated ...
openaire   +3 more sources

Selection of Single-Domain Antibodies towards Western Equine Encephalitis Virus

open access: yesAntibodies, 2018
In this work, we describe the selection and characterization of single-domain antibodies (sdAb) towards the E2/E3E2 envelope protein of the Western equine encephalitis virus (WEEV).
Jinny L. Liu   +4 more
doaj   +1 more source

Identification of a Fully Human Antibody VH Domain Targeting Anaplastic Lymphoma Kinase (ALK) with Applications in ALK-Positive Solid Tumor Immunotherapy

open access: yesAntibodies
The anaplastic lymphoma kinase (ALK, CD247) is a potential target for antibody-based therapy. However, no antibody-based therapeutics targeting ALK have entered clinical trials, necessitating the development of novel antibodies with unique therapeutic ...
Chuan Chen   +7 more
doaj   +1 more source

Isolation and characterization of camelid single-domain antibodies against HER2

open access: yesBMC Research Notes, 2018
Objective To isolate and characterize novel high-affinity llama single-domain antibodies against human HER2. Results We immunized a llama with human HER2, constructed a phage-displayed VHH library from the lymphocytes of the animal, and isolated six ...
Greg Hussack   +3 more
doaj   +1 more source

Single domain antibodies in tissue engineering [PDF]

open access: yes, 2014
The aim of this thesis is to demonstrate the potential of VHH in tissue engineering applications, with a focus on bone and cartilage tissue regeneration. After a general introduction to this thesis in chapter 1, the selection of VHH targeting growth factors is described in chapter 2.
openaire   +2 more sources

Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: implications for B-cell selection

open access: yes, 2018
Autoreactive B cells have a central role in the pathogenesis of rheumatoid arthritis (RA), and recent findings have proposed that anti-citrullinated protein autoantibodies (ACPA) may be directly pathogenic.
Amara, Khaled   +17 more
core   +2 more sources

Preclinical synergistic effects when combining a radiolabelled HER2-targeting single domain antibody with PARP inhibitor Olaparib

open access: yesJournal of Translational Medicine
Background The HER2 targeted therapy paradigm has increasingly shifted in recent years from focussed treatment of only cancers with high HER2 expression towards those with also low HER2 expression, unlocking a larger subset of patients, in either single ...
Jonatan Dewulf   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy